What is the recommended initial imaging for a patient with suspected pancreatitis or a pancreas cyst?

Imaging for Pancreatitis and Pancreatic Cysts

Acute Pancreatitis

For suspected acute pancreatitis, initial imaging is NOT routinely recommended in the first week unless there is clinical deterioration or uncertainty in diagnosis; when imaging is needed, contrast-enhanced CT with pancreas protocol is the modality of choice. 1

When to Image in Acute Pancreatitis

• Early CT (first 4 days) is generally NOT indicated because the full extent of necrosis takes at least 4 days to develop, and early scanning may underestimate disease severity 1
• Anxieties persist about potential extension of necrosis and exacerbation of renal impairment from IV contrast in the acute phase 1
• CT is indicated when:
  • Clinical impression suggests severe disease with organ failure 1
  • APACHE II score >8, Glasgow score ≥3, or CRP >150 mg/L at 24-48 hours 1
  • BMI >30, pleural effusion on chest X-ray, or persisting organ failure 1
  • Clinical status deteriorates or fails to improve 1
  • Management decisions depend on extent of necrosis (e.g., prophylactic antibiotics) 1

CT Protocol for Acute Pancreatitis

Spiral or multislice CT with dedicated pancreas protocol is required, and CT without IV contrast enhancement gives suboptimal information and should be avoided. 1

• Oral contrast: 500 mL by mouth or nasogastric tube 1
• Initial non-contrast scan to identify pancreatic levels and demonstrate peripancreatic changes 1
• IV contrast protocol: 100 mL non-ionic contrast at 3 mL/s via power injector 1
• Thin collimation (≤5 mm) through pancreatic bed starting 40 seconds after injection 1
• Portal venous phase at 65 seconds for peripancreatic vein patency 1
• Non-opacification of ≥1/3 of pancreas or area >3 cm indicates necrosis 1

CT Severity Grading (Balthazar Index)

Use the CT severity index for staging when imaging is performed 1:

• CT Grade: Normal (0) → Edematous (1) → Mild extrapancreatic changes (2) → Severe extrapancreatic changes with one collection (3) → Multiple collections (4) 1
• Necrosis Score: None (0) → <1/3 (2) → 1/3-1/2 (4) → >1/2 (6) 1
• CT Severity Index = Grade + Necrosis Score 1
• Mortality correlates with severity: 0-3 (3%), 4-6 (6%), 7-10 (17%) 1

Follow-up Imaging in Acute Pancreatitis

• Mild pancreatitis or CT severity index 0-2: Further CT only if clinical status changes 1
• CT severity index 3-10: Additional scans only if deterioration or failure to improve 1
• Consider single scan before discharge in apparently uncomplicated recovery to detect asymptomatic pseudocyst or arterial pseudoaneurysm 1

---

Pancreatic Cysts

For incidentally detected pancreatic cysts, MRI abdomen without and with IV contrast with MRCP is the preferred initial imaging modality, with no routine laboratory testing required. 1, 2, 3

Initial Imaging Based on Cyst Size

• Cysts ≤2.5 cm: MRI with MRCP is usually appropriate 1
• Cysts >2.5 cm without high-risk features: MRI with MRCP is usually appropriate 1
• Cysts >2.5 cm with high-risk stigmata or worrisome features: Both endoscopic ultrasound (EUS) and MRI with MRCP are usually appropriate as complementary procedures 1

Why MRI/MRCP is Superior to CT

MRI with MRCP achieves 96.8% sensitivity and 90.8% specificity for distinguishing IPMN from other cystic lesions, compared to CT's 80.6% sensitivity and 86.4% specificity. 2, 3

• MRCP demonstrates 100% sensitivity for detecting cyst communication with main pancreatic duct versus 86% for CT 3
• MRI detects internal septations with 91% sensitivity versus CT's 73.9-93.6% 3
• MRI identifies mural nodules more reliably than CT (CT sensitivity only 71.4%) 3
• Superior soft tissue contrast for evaluating cyst wall thickness, enhancement, and internal architecture 1, 2, 3
• No radiation exposure, critical for lifelong surveillance imaging 3

MRI/MRCP Protocol Requirements

• T2-weighted sequences for cyst characterization and internal architecture 1, 2, 3
• Thin-slice 3D MRCP sequences for maximum sensitivity in detecting ductal communication 3
• Dual-phase contrast-enhanced T1-weighted imaging (late arterial and portal venous phases) when gadolinium is administered 1, 2, 3
• MRCP sequences to evaluate pancreatic ductal anatomy 1, 2

High-Risk Stigmata Requiring Surgical Consultation

• Enhancing solid component within the cyst 3
• Main pancreatic duct ≥10 mm diameter 3
• Obstructive jaundice with cystic lesion in pancreatic head 3

Worrisome Features Prompting Closer Surveillance or EUS-FNA

• Cyst size ≥3 cm (3-times greater malignancy risk) 1, 3
• Thickened or enhancing cyst wall 1, 3
• Non-enhancing mural nodules 3
• Main pancreatic duct caliber 5-9 mm 3
• Communication with main pancreatic duct suggests IPMN 3

Role of Laboratory Testing

The American College of Radiology does not recommend routine laboratory tests, including serum tumor markers, for initial characterization of small, asymptomatic pancreatic cysts. 2

• Laboratory testing only indicated if clinical symptoms suggest complications, obstructive jaundice is present, or EUS-FNA is performed 2

Role of EUS-FNA

• EUS-FNA is complementary to MRCP, not a replacement 3
• Consider for cysts ≥3 cm even without other concerning features 3
• Provides tissue diagnosis when MRCP shows worrisome features or high-risk stigmata 3
• Requires at least 2 mL aspirated fluid (corresponding to 1.7 cm cyst size) for adequate cytology and biomarker analysis 3

Follow-up Imaging

• Either CT or MRI acceptable for surveillance of established cysts 1, 3
• Modality concordance between baseline and follow-up facilitates comparison 1, 3
• Risk of malignant transformation approximately 0.24% per year 1, 2
• Cysts <5 mm may require one follow-up at 2 years; stability at 2 years sufficient to stop surveillance 1

Common Pitfalls

• Avoid CT without IV contrast for pancreatic imaging—it provides suboptimal information 1
• Do not order early CT in acute pancreatitis unless there is clinical deterioration or severe disease indicators 1
• Do not rely on CT alone for small pancreatic cysts—MRI/MRCP is superior for characterization and detecting worrisome features 2, 3
• Location in pancreatic head warrants attention due to risk of obstructive jaundice; main pancreatic duct caliber is critical 2